A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice

Akane Ishihara, Akio Kanatani, Satoshi Mashiko, Takeshi Tanaka, Masayasu Hidaka, Akira Gomori, Hisashi Iwaasa, Naomi Murai, Shin Ichiro Egashira, Takashi Murai, Yuko Mitobe, Hiroko Matsushita, Osamu Okamoto, Nagaaki Sato, Makoto Jitsuoka, Takahiro Fukuroda, Tomoyuki Ohe, Xiaoming Guan, Douglas J. MacNeil, Lex M T Van Der PloegMasaru Nishikibe, Yasuyuki Ishii, Masaki Ihara, Takehiro Fukami

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Neuropeptide Y (NPY) is thought to have a major role in the physiological control of energy homeostasis. Among five NPY receptors described, the NPY Y5 receptor (Y5R) is a prime candidate to mediate some of the effects of NPY on energy homeostasis, although its role in physiologically relevant rodent obesity models remains poorly defined. We examined the effect of a potent and highly selective Y5R antagonist in rodent obesity and dietary models. The Y5R antagonist selectively ameliorated diet-induced obesity (DIO) in rodents by suppressing body weight gain and adiposity while improving the DIO-associated hyperinsulinemia. The compound did not affect the body weight of lean mice fed a regular diet or genetically obese leptin receptor-deficient mice or rats, despite similarly high brain Y5R receptor occupancy. The Y5R antagonist acts in a mechanism-based manner, as the compound did not affect DIO of Y5R-deficient mice. These results indicate that Y5R is involved in the regulation and development of DIO and suggest utility for Y5R antagonists in the treatment of obesity.

Original languageEnglish
Pages (from-to)7154-7158
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume103
Issue number18
DOIs
Publication statusPublished - 2006 May 2
Externally publishedYes

Fingerprint

Obese Mice
Neuropeptide Y
Weight Gain
Obesity
Body Weight
Diet
Neuropeptide Y Receptors
Rodentia
Homeostasis
Adiposity
Hyperinsulinism
Brain

Keywords

  • Antiobesity effect
  • Receptor occupancy
  • Y5R-deficient mice

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. / Ishihara, Akane; Kanatani, Akio; Mashiko, Satoshi; Tanaka, Takeshi; Hidaka, Masayasu; Gomori, Akira; Iwaasa, Hisashi; Murai, Naomi; Egashira, Shin Ichiro; Murai, Takashi; Mitobe, Yuko; Matsushita, Hiroko; Okamoto, Osamu; Sato, Nagaaki; Jitsuoka, Makoto; Fukuroda, Takahiro; Ohe, Tomoyuki; Guan, Xiaoming; MacNeil, Douglas J.; Van Der Ploeg, Lex M T; Nishikibe, Masaru; Ishii, Yasuyuki; Ihara, Masaki; Fukami, Takehiro.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 103, No. 18, 02.05.2006, p. 7154-7158.

Research output: Contribution to journalArticle

Ishihara, A, Kanatani, A, Mashiko, S, Tanaka, T, Hidaka, M, Gomori, A, Iwaasa, H, Murai, N, Egashira, SI, Murai, T, Mitobe, Y, Matsushita, H, Okamoto, O, Sato, N, Jitsuoka, M, Fukuroda, T, Ohe, T, Guan, X, MacNeil, DJ, Van Der Ploeg, LMT, Nishikibe, M, Ishii, Y, Ihara, M & Fukami, T 2006, 'A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice', Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7154-7158. https://doi.org/10.1073/pnas.0510320103
Ishihara, Akane ; Kanatani, Akio ; Mashiko, Satoshi ; Tanaka, Takeshi ; Hidaka, Masayasu ; Gomori, Akira ; Iwaasa, Hisashi ; Murai, Naomi ; Egashira, Shin Ichiro ; Murai, Takashi ; Mitobe, Yuko ; Matsushita, Hiroko ; Okamoto, Osamu ; Sato, Nagaaki ; Jitsuoka, Makoto ; Fukuroda, Takahiro ; Ohe, Tomoyuki ; Guan, Xiaoming ; MacNeil, Douglas J. ; Van Der Ploeg, Lex M T ; Nishikibe, Masaru ; Ishii, Yasuyuki ; Ihara, Masaki ; Fukami, Takehiro. / A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice. In: Proceedings of the National Academy of Sciences of the United States of America. 2006 ; Vol. 103, No. 18. pp. 7154-7158.
@article{89b6f988b44e4e249ee5038ed79b4be6,
title = "A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice",
abstract = "Neuropeptide Y (NPY) is thought to have a major role in the physiological control of energy homeostasis. Among five NPY receptors described, the NPY Y5 receptor (Y5R) is a prime candidate to mediate some of the effects of NPY on energy homeostasis, although its role in physiologically relevant rodent obesity models remains poorly defined. We examined the effect of a potent and highly selective Y5R antagonist in rodent obesity and dietary models. The Y5R antagonist selectively ameliorated diet-induced obesity (DIO) in rodents by suppressing body weight gain and adiposity while improving the DIO-associated hyperinsulinemia. The compound did not affect the body weight of lean mice fed a regular diet or genetically obese leptin receptor-deficient mice or rats, despite similarly high brain Y5R receptor occupancy. The Y5R antagonist acts in a mechanism-based manner, as the compound did not affect DIO of Y5R-deficient mice. These results indicate that Y5R is involved in the regulation and development of DIO and suggest utility for Y5R antagonists in the treatment of obesity.",
keywords = "Antiobesity effect, Receptor occupancy, Y5R-deficient mice",
author = "Akane Ishihara and Akio Kanatani and Satoshi Mashiko and Takeshi Tanaka and Masayasu Hidaka and Akira Gomori and Hisashi Iwaasa and Naomi Murai and Egashira, {Shin Ichiro} and Takashi Murai and Yuko Mitobe and Hiroko Matsushita and Osamu Okamoto and Nagaaki Sato and Makoto Jitsuoka and Takahiro Fukuroda and Tomoyuki Ohe and Xiaoming Guan and MacNeil, {Douglas J.} and {Van Der Ploeg}, {Lex M T} and Masaru Nishikibe and Yasuyuki Ishii and Masaki Ihara and Takehiro Fukami",
year = "2006",
month = "5",
day = "2",
doi = "10.1073/pnas.0510320103",
language = "English",
volume = "103",
pages = "7154--7158",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "18",

}

TY - JOUR

T1 - A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice

AU - Ishihara, Akane

AU - Kanatani, Akio

AU - Mashiko, Satoshi

AU - Tanaka, Takeshi

AU - Hidaka, Masayasu

AU - Gomori, Akira

AU - Iwaasa, Hisashi

AU - Murai, Naomi

AU - Egashira, Shin Ichiro

AU - Murai, Takashi

AU - Mitobe, Yuko

AU - Matsushita, Hiroko

AU - Okamoto, Osamu

AU - Sato, Nagaaki

AU - Jitsuoka, Makoto

AU - Fukuroda, Takahiro

AU - Ohe, Tomoyuki

AU - Guan, Xiaoming

AU - MacNeil, Douglas J.

AU - Van Der Ploeg, Lex M T

AU - Nishikibe, Masaru

AU - Ishii, Yasuyuki

AU - Ihara, Masaki

AU - Fukami, Takehiro

PY - 2006/5/2

Y1 - 2006/5/2

N2 - Neuropeptide Y (NPY) is thought to have a major role in the physiological control of energy homeostasis. Among five NPY receptors described, the NPY Y5 receptor (Y5R) is a prime candidate to mediate some of the effects of NPY on energy homeostasis, although its role in physiologically relevant rodent obesity models remains poorly defined. We examined the effect of a potent and highly selective Y5R antagonist in rodent obesity and dietary models. The Y5R antagonist selectively ameliorated diet-induced obesity (DIO) in rodents by suppressing body weight gain and adiposity while improving the DIO-associated hyperinsulinemia. The compound did not affect the body weight of lean mice fed a regular diet or genetically obese leptin receptor-deficient mice or rats, despite similarly high brain Y5R receptor occupancy. The Y5R antagonist acts in a mechanism-based manner, as the compound did not affect DIO of Y5R-deficient mice. These results indicate that Y5R is involved in the regulation and development of DIO and suggest utility for Y5R antagonists in the treatment of obesity.

AB - Neuropeptide Y (NPY) is thought to have a major role in the physiological control of energy homeostasis. Among five NPY receptors described, the NPY Y5 receptor (Y5R) is a prime candidate to mediate some of the effects of NPY on energy homeostasis, although its role in physiologically relevant rodent obesity models remains poorly defined. We examined the effect of a potent and highly selective Y5R antagonist in rodent obesity and dietary models. The Y5R antagonist selectively ameliorated diet-induced obesity (DIO) in rodents by suppressing body weight gain and adiposity while improving the DIO-associated hyperinsulinemia. The compound did not affect the body weight of lean mice fed a regular diet or genetically obese leptin receptor-deficient mice or rats, despite similarly high brain Y5R receptor occupancy. The Y5R antagonist acts in a mechanism-based manner, as the compound did not affect DIO of Y5R-deficient mice. These results indicate that Y5R is involved in the regulation and development of DIO and suggest utility for Y5R antagonists in the treatment of obesity.

KW - Antiobesity effect

KW - Receptor occupancy

KW - Y5R-deficient mice

UR - http://www.scopus.com/inward/record.url?scp=33646482230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646482230&partnerID=8YFLogxK

U2 - 10.1073/pnas.0510320103

DO - 10.1073/pnas.0510320103

M3 - Article

C2 - 16636293

AN - SCOPUS:33646482230

VL - 103

SP - 7154

EP - 7158

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 18

ER -